India bans corona vaccine exports
The Indian government has banned Seram Institute, a corona vaccine manufacturer in India, from exporting the Oxford-estrogen vaccine. Due to the ban, other countries, including Bangladesh, which has an agreement with India, may have to wait a few more months to get the vaccine.
Earlier, on January 1, India approved the emergency application of the Oxford AstraZeneca Covid-19 vaccine.
Adar Punawalla, CEO of the Serum Institute of India, said on Sunday that Indian policy-making authorities had given urgent approval to the vaccine. But the condition is to ensure the dose for the Indian people at risk. Therefore, Serum Institute will not be able to export.
He added that Serum would not be able to sell the vaccine in the private market at the moment. They can only hand over the vaccine to the Indian government at the moment.
It may be mentioned that on November 5, Beximco Pharmaceuticals of Bangladesh had signed an agreement with Serum Institute to get 30 million doses of Oxford-produced ‘Covidshield’ vaccine. Under this initiative, Serum was to give 5 million vaccines to Bangladesh every month for 6 months in the first phase. However, India's sudden decision to stop exports may make Bangladesh wait longer to get the vaccine.
In addition, more than one crore people in India have been affected by corona. Which is the second highest in the world. About 1.5 lakh people have died in Corona in the country. India wants to vaccinate 300 million people from the very beginning of the corona vaccine distribution scheme. Among them, health workers, police and front line fighters are getting priority.